Pharma-Pen (Formerly Innoject) Auto-injectory TIV

首次发布于 2006 年 6 月 12 日

Bioequivalence Study of Vildagliptin From Gliptus 50 mg Tablet (EVA Pharma, Egypt) and Galvus 50 mg Tablet (NOVARTIS PHARMA, GERMANY)

计划入组 24 人 · 首次发布于 2016 年 6 月 29 日

Exjade-Early-Trial

计划入组 2 人 · 首次发布于 2010 年 1 月 28 日

XEN-D0501

undisclosed antibodies

Thalidomide inhalation (Vicore Pharma)

Pila Pharma AB

Sweden

Bioprojet Pharma

Belgium

ACASTI PHARMA INC

United States

PILA PHARMA's XEN-D0501 Investigated for Abdominal Aortic Aneurysm Treatment in Preclinical Study

Pila Pharma Advances PP-CT03 Trial for XEN-D0501 in Type 2 Diabetes and Obesity

PILA PHARMA Advances to Clinical Obesity Trials Despite Inconclusive Preclinical Results